Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CVS Health's other long-term assets for the quarter that ended in Jun. 2026 was CHF5,942 Mil.
CVS Health's quarterly other long-term assets
increased
from Dec. 2025 (CHF5,668 Mil) to Mar. 2026 (CHF5,845 Mil) and
increased
from Mar. 2026 (CHF5,845 Mil) to Jun. 2026 (CHF5,942 Mil).
CVS Health's annual other long-term assets
increased
from Dec. 2023 (CHF6,841 Mil) to Dec. 2024 (CHF7,226 Mil) but then
declined
from Dec. 2024 (CHF7,226 Mil) to Dec. 2025 (CHF5,668 Mil).
The historical data trend for CVS Health's Other Long Term Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.
What does a Other Long Term Assets of CHF5,942 Mil mean?
CVS Health (XSWX:CVS) has a Other Long Term Assets of CHF5,942 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on CVS Health and its competitors.
Is CVS Health's Other Long Term Assets too high?
CVS Health's current Other Long Term Assets is CHF5,942 Mil. Overall, CVS Health has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does CVS Health's Other Long Term Assets compare to ELV and CI?
CVS Health's Other Long Term Assets of CHF5,942 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Plans company?
A good Other Long Term Assets depends on the Healthcare Plans industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on CVS Health and its competitors. CVS Health's current Other Long Term Assets is CHF5,942 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
CVS Health (XSWX:CVS) has a current Other Long Term Assets of CHF5,942 Mil. The stock's GF Value™ is CHF63.11, compared to a current price of CHF75.02 — trading 18.9% above its estimated fair value. The current Other Long Term Assets is CHF5,942 Mil. CVS Health's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For CVS Health (XSWX:CVS), the current Other Long Term Assets is CHF5,942 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Health (XSWX:CVS) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Health stock appears to be overvalued.
The current stock price of CHF75.02 is trading 18.9% above its estimated GF Value™ of CHF63.11.
Key valuation signals for XSWX:CVS:
Other Long Term Assets: CHF5,942 Mil
GF Value™: CHF63.11 vs. price of CHF75.02 (18.9% above fair value)
No single metric tells the full story. See the XSWX:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
76GF Score
Get the complete analysis for XSWX:CVS
Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CVS has been successfully added to your 
